Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’
The Pharma Data
MAY 5, 2021
New variant-hardy AbCellera-Lilly mAb shows utility of viral genomics surveillance ( BioCentury ). BD Taps Contract Packager for COVID-19 Test Kits ( MD+DI ). My Conversation with Daniel Carpenter, on regulation and also the FDA ( Marginal Revolution ). Medtech.
52 
Let's personalize your content